Related Experiment Videos
A new parasympathomimetic agent: 1-methyl-5-chloroindoline methylbromide
Japanese Journal of Pharmacology
|June 1, 1971
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Individual monitoring for external exposure of workers in FDNPS.
Annals of the ICRP·2026
Epidemiology of paediatric elbow fractures: a retrospective multi-centre study of 488 fractures.
Journal of children's orthopaedics·2019
Dietary Intake Is Associated with Occlusal Force Rather Than Number of Teeth in 80-y-Old Japanese.
JDR clinical and translational research·2019
Molecular phylogenetic position of podostemaceae, a marvelous aquatic flowering plant family.
Journal of plant research·2016
Structural alterations of the superior temporal gyrus in schizophrenia: Detailed subregional differences.
European psychiatry : the journal of the Association of European Psychiatrists·2016
Role of renin-angiotensin system and nuclear factor-kappaB in the obstructed kidney of rats with unilateral ureteral obstruction.
Japanese journal of pharmacology·2002
A polysaccharide, extract from Grifola frondosa, induces Th-1 dominant responses in carcinoma-bearing BALB/c mice.
Japanese journal of pharmacology·2002
In vivo evidence for a lack of central effect of ebastine, an antihistaminic agent, in rats: a microdialysis study.
Japanese journal of pharmacology·2002
Ginkgo biloba extract markedly induces pentoxyresorufin O-dealkylase activity in rats.
Japanese journal of pharmacology·2002
Possible involvement of suppression of Th2 differentiation in the anti-allergic effect of Sho-seiryu-to in mice.
Japanese journal of pharmacology·2002
SiaRNA: a siamese neural network with bidirectional cross-attention for pairwise siRNA-mRNA efficacy prediction.
Frontiers in bioinformatics·2026
Beyond Antioxidant Activity: Redox-Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera.
Journal of experimental pharmacology·2026
Novel Compounds as 5‑HT2A Agonists for Treating Mental Illness or CNS Disorders.
ACS medicinal chemistry letters·2026